Biocorrx Inc. (OTCMKTS:BICX) Sees Large Increase in Short Interest

Biocorrx Inc. (OTCMKTS:BICX) was the recipient of a significant growth in short interest in the month of July. As of July 15th, there was short interest totaling 1,741 shares, a growth of ∞ from the June 30th total of 0 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily trading volume, of 3,240 shares, the short-interest ratio is currently 0.5 days.

Biocorrx Stock Performance

Shares of Biocorrx stock opened at $0.30 on Friday. Biocorrx has a 1 year low of $0.20 and a 1 year high of $1.28. The company has a market cap of $8.90 million, a P/E ratio of -1.88 and a beta of 0.17. The stock has a 50-day moving average price of $0.34 and a 200 day moving average price of $0.35.

Biocorrx (OTCMKTS:BICX) last issued its earnings results on Friday, May 15th. The company reported ($0.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.03. The business had revenue of $0.21 million during the quarter, compared to analyst estimates of $0.22 million.

Biocorrx Company Profile

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.